FDA Inspection 1342038 — Vitalant

Vitalant — FEI 3003609162

The FDA completed an inspection of Vitalant on Oct 16, 2026 in Elk Grove, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 16, 2026
Fiscal Year
2027
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Elk Grove, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.